Download PDF
Open Access
CC BY 4.0 · World J Nucl Med 2023; 22(04): 257-260
DOI: 10.1055/s-0043-1774419
Original Article

How Radioactive Iodine Treatment Affects the Retina

Authors

  • Ceren Gürez 

    1   Ophthalmology Clinic, Beyoglu Eye Training and Research Hospital, Health of Sciences University, Turkey

  • Aynur Özen 

    2   Nuclear Medicine Clinic, Bagcilar Training and Research Hospital, Health of Sciences University, Turkey

  • Özgül Ekmekçioğlu 

    3   Nuclear Medicine Clinic, Sisli Hamidiye Etfal Training and Research Hospital, Health of Sciences University, Turkey
Further Information
Also available at
  Permissions and Reprints

Abstract

Objective The aim of this study was to quantitatively assess the macular and retinal nerve fiber layer thicknesses in patients with hyperthyroidism and thyroid cancer undergoing radioactive iodine (RAI) therapy.

Study Design This prospective study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Bagcilar Training and Research Hospital Clinical Research Ethics Committee. Written informed consent was obtained from the patients following a detailed explanation of the study objectives and protocol. Patient selection was randomized. Patients scheduled for RAI treatment in the Nuclear Medicine Clinic were referred to the ophthalmology clinic, respectively. Patients without additional ocular pathology were included in the study.

Methods All patients had received RAI therapy using Iodine-131 for hyperthyroidism or thyroid cancer. A complete ophthalmological examination and measurement of macular and retinal nerve fiber layer thickness using optical coherence tomography were performed on all patients before and at the first and sixth months and in first year after RAI treatment. The results were prospectively evaluated.

Results The study included 80 eyes of 40 patients. The hyperthyroid group was group 1, and the thyroid cancer group was group 2. There were 25 patients in group 1 and 15 patients in group 2. The mean age was 43.76 ± 11.85 years (range: 22–65 years) in group 1 and 39.87 ± 9.13 years (range: 30–58 years) in group 2. There was no significant difference between the two groups regarding age and sex (p > 0.05). In both groups, no significant difference was found in the macular thickness and retinal nerve fiber layer thicknesses values obtained in both eyes before and after the RAI treatment.

Conclusion As a result of our study, we observed that RAI intake did not harm the retinal layer.

Keywords

Macula - nerve fiber layer - radioactive iodine - thyroid cancer - hyperthyroidism

Authors' Contribution

Ceren Gürez was involved in patient selection, data collection, and writing. Aynur Özen and Özgül Ekmekçioğlu helped in patient selection and data collection.


Ethical Approval

The study was reviewed and approved by the Bagcilar Training and Research Hospital Ethics Committee with the 2014-319 registration number by principles of the Declaration of Helsinki and, written informed consent was obtained from all patients.




Publication History

Article published online:
04 December 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India